Cao Jiasheng, Hu Jiahao, Shen Jiliang, Zhang Bin, Topatana Win, Li Shijie, Chen Tianen, Jeungpanich Sarun, Tian Yitong, Lu Ziyi, Peng Shuyou, Cai Xiujun, Chen Mingyu
Department of General Surgery, Sir Run-Run Shaw Hospital, Zhejiang University, Hangzhou 310016, Zhejiang Province, China.
Zhejiang University School of Medicine, Zhejiang University, Hangzhou 310058, Zhejiang Province, China.
ILIVER. 2022 Jul 14;1(2):127-138. doi: 10.1016/j.iliver.2022.06.004. eCollection 2022 Jun.
To date, no comprehensive analysis of gallbladder cancer (GBC) management has been reported. We aimed to identify the publication characteristics and research trends in managing GBC over the past three decades.
We selected the 100 most cited articles and performed a bibliometric analysis to summarize the publication characteristics, explore research hotspots, and identify research trends in the management of GBC.
The total citations of the included articles ranged from 123 to 1822. Period II (2001-2010) yielded the highest number of included articles, whereas the lowest was in Period III (2011-2020). The United States and Japan published the most papers, in which the Memorial Sloan-Kettering Cancer Center and Nagoya University were the leading institutions, respectively. The most influential authors were Blumgart LH and Fong YM from the United States. Cooperation among countries, institutions, and authors was weak. The contributed the most articles with the highest number of total citations. The most researched topic was surgery, followed by systemic therapy and adjuvant therapy. Since Period I, the percentage of surgery-related publications continuously decreased (Periods II and III versus Period I, both < 0.001), with a concomitant increase in those of adjuvant therapy (Period III versus Period I, = 0.004) and systemic therapy (Period II versus Period I, = 0.004; Period III versus Period I, = 0.002).
Surgery remains the preferred treatment, while there is a tendency toward adjuvant and systemic therapy in GBC management. An increase in local and international collaboration for managing GBC is required.
迄今为止,尚未有关于胆囊癌(GBC)治疗的全面分析报告。我们旨在确定过去三十年中GBC治疗的发表特征和研究趋势。
我们选择了被引用次数最多的100篇文章,并进行文献计量分析,以总结发表特征、探索研究热点并确定GBC治疗的研究趋势。
纳入文章的总被引用次数在123至1822次之间。第二期(2001 - 2010年)纳入的文章数量最多,而第三期(2011 - 2020年)最少。美国和日本发表的论文最多,其中纪念斯隆凯特琳癌症中心和名古屋大学分别是领先机构。最具影响力的作者是来自美国的布卢姆加特·L·H和方·Y·M。国家、机构和作者之间的合作较为薄弱。 贡献的文章最多,总被引用次数也最高。研究最多的主题是手术,其次是全身治疗和辅助治疗。自第一期以来,与手术相关的出版物百分比持续下降(第二期和第三期与第一期相比,均 < 0.001),辅助治疗(第三期与第一期相比, = 0.004)和全身治疗(第二期与第一期相比, = 0.004;第三期与第一期相比, = 0.002)的出版物百分比则随之增加。
手术仍然是首选治疗方法,而在GBC治疗中存在向辅助治疗和全身治疗发展的趋势。需要加强GBC治疗方面的国内外合作。